You are here: Industry Insights > Brain Tumors

News List

Treovir Announces Opening of G207 Phase 2 Clinical Trial in Children with Recurrent Brain Tumors Biotech Newswire
December 05, 2024
Treovir, Inc. announced today the opening of a Phase 2 trial testing G207, an oncolytic HSV immunotherapy, in pediatric brain tumor patients.
Targeted drug combination shows unprecedented activity in some highly aggressive brain tumors WorldPharmaNews
November 26, 2021
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation...
NaviFUS begins FUS combined with radiotherapy clinical trial for the treatment of terminal primary brain tumors prnasia
August 04, 2021
NaviFUS' focused ultrasound (FUS) therapy system (NaviFUS®) was recently approved for use in a new clinical trial by the Taiwan, China Food and Drug Administration (TFDA).
The Mikey Czech Foundation Contributes $1 Million To DIPG Research At Dana-Farber Cancer Institute en-cphi.cn
March 30, 2017
The Mikey Czech Foundation, Inc. announced a $1,000,000 gift to Pediatric Medical Neuro-Oncology at Dana-Farber, headed by Mark W. Kieran, MD, PhD, and located in Boston, Massachusetts.